

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent advances in allergic rhinitis | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/7-1333/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/7-1333" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent advances in allergic rhinitis" />
    
            <meta name="og:title" content="F1000Research Article: Recent advances in allergic rhinitis.">
            <meta name="og:description" content="Read the latest article version by Flavia C. L. Hoyte, Harold S. Nelson, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="16746">
            <meta name="article-id" content="15367">
            <meta name="dc.title" content="Recent advances in allergic rhinitis">
            <meta name="dc.description" content="Allergic rhinitis affects 20 to 30% of adults in both the United States and Europe and perhaps a somewhat higher percentage of children. In addition to nasal and ocular symptoms directly related to the allergic process, interference of these symptoms with sleep leads to daytime sleepiness and impaired quality of life. Patients miss work because of symptoms but an even greater problem is interference with work productivity, or presenteeism, which has been reported to be the biggest contributor to the total economic cost of allergic rhinitis. There has been increasing awareness that many patients with either seasonal or perennial symptoms but negative skin and in vitro tests for allergen sensitivity have local nasal allergy, diagnosable by the presence of allergen-specific IgE in their nasal secretions or a positive nasal allergen challenge or both. The pharmaceutical management of allergic rhinitis rests on symptomatic treatment with antihistamines that perhaps are more effectively administered intranasally than orally and intranasal corticosteroids. Allergen immunotherapy is very effective, even for local allergic rhinitis, and the shortcomings of subcutaneous immunotherapy of inconvenience and safety are reduced by the introduction of sublingual immunotherapy (SLIT). Use of the latter is currently somewhat limited by the lack of appropriate dosing information for SLIT liquids and the limited number of allergens for which SLIT tablets are available.">
            <meta name="dc.subject" content="Allergic Rhinitis, Local nasal allergy, Immunotherapy, SCIT, SLIT">
            <meta name="dc.creator" content="Hoyte, Flavia C. L.">
            <meta name="dc.creator" content="Nelson, Harold S.">
            <meta name="dc.date" content="2018/08/23">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.15367.1">
            <meta name="dc.source" content="F1000Research 2018 7:1333">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="Allergic Rhinitis">
            <meta name="prism.keyword" content="Local nasal allergy">
            <meta name="prism.keyword" content="Immunotherapy">
            <meta name="prism.keyword" content="SCIT">
            <meta name="prism.keyword" content="SLIT">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2018/08/23">
            <meta name="prism.volume" content="7">
            <meta name="prism.number" content="1333">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.15367.1">
            <meta name="prism.url" content="https://f1000research.com/articles/7-1333">
            <meta name="citation_title" content="Recent advances in allergic rhinitis">
            <meta name="citation_abstract" content="Allergic rhinitis affects 20 to 30% of adults in both the United States and Europe and perhaps a somewhat higher percentage of children. In addition to nasal and ocular symptoms directly related to the allergic process, interference of these symptoms with sleep leads to daytime sleepiness and impaired quality of life. Patients miss work because of symptoms but an even greater problem is interference with work productivity, or presenteeism, which has been reported to be the biggest contributor to the total economic cost of allergic rhinitis. There has been increasing awareness that many patients with either seasonal or perennial symptoms but negative skin and in vitro tests for allergen sensitivity have local nasal allergy, diagnosable by the presence of allergen-specific IgE in their nasal secretions or a positive nasal allergen challenge or both. The pharmaceutical management of allergic rhinitis rests on symptomatic treatment with antihistamines that perhaps are more effectively administered intranasally than orally and intranasal corticosteroids. Allergen immunotherapy is very effective, even for local allergic rhinitis, and the shortcomings of subcutaneous immunotherapy of inconvenience and safety are reduced by the introduction of sublingual immunotherapy (SLIT). Use of the latter is currently somewhat limited by the lack of appropriate dosing information for SLIT liquids and the limited number of allergens for which SLIT tablets are available.">
            <meta name="citation_description" content="Allergic rhinitis affects 20 to 30% of adults in both the United States and Europe and perhaps a somewhat higher percentage of children. In addition to nasal and ocular symptoms directly related to the allergic process, interference of these symptoms with sleep leads to daytime sleepiness and impaired quality of life. Patients miss work because of symptoms but an even greater problem is interference with work productivity, or presenteeism, which has been reported to be the biggest contributor to the total economic cost of allergic rhinitis. There has been increasing awareness that many patients with either seasonal or perennial symptoms but negative skin and in vitro tests for allergen sensitivity have local nasal allergy, diagnosable by the presence of allergen-specific IgE in their nasal secretions or a positive nasal allergen challenge or both. The pharmaceutical management of allergic rhinitis rests on symptomatic treatment with antihistamines that perhaps are more effectively administered intranasally than orally and intranasal corticosteroids. Allergen immunotherapy is very effective, even for local allergic rhinitis, and the shortcomings of subcutaneous immunotherapy of inconvenience and safety are reduced by the introduction of sublingual immunotherapy (SLIT). Use of the latter is currently somewhat limited by the lack of appropriate dosing information for SLIT liquids and the limited number of allergens for which SLIT tablets are available.">
            <meta name="citation_keywords" content="Allergic Rhinitis, Local nasal allergy, Immunotherapy, SCIT, SLIT">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Flavia C. L. Hoyte">
            <meta name="citation_author_institution" content="Department of Medicine, Division of Allergy/Immunology, National Jewish Health, Denver, CO, 80206, USA">
            <meta name="citation_author" content="Harold S. Nelson">
            <meta name="citation_author_institution" content="Department of Medicine, Division of Allergy/Immunology, National Jewish Health, Denver, CO, 80206, USA">
            <meta name="citation_publication_date" content="2018/08/23">
            <meta name="citation_volume" content="7">
            <meta name="citation_publication_number" content="1333">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.15367.1">
            <meta name="citation_firstpage" content="1333">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/7-1333/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/7-1333.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=16746 /> <input type=hidden id=articleId name=articleId value=15367 /> <input type=hidden id=xmlUrl value="/articles/7-1333/v1/xml"/> <input type=hidden id=xmlFileName value="-7-1333-v1.xml"> <input type=hidden id=article_uuid value=6b3fe346-bb91-462d-9ad0-b3f2c743ca8c /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent advances in allergic rhinitis"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.15367.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.15367.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/7-1333"
  },
  "headline": "Recent advances in allergic rhinitis",
  "datePublished": "2018-08-23T16:20:15",
  "dateModified": "2018-08-23T16:20:15",
  "author": [
    {
      "@type": "Person",
      "name": "Flavia C. L. Hoyte"
    },    {
      "@type": "Person",
      "name": "Harold S. Nelson"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Allergic rhinitis affects 20 to 30% of adults in both the United States and Europe and perhaps a somewhat higher percentage of children. In addition to nasal and ocular symptoms directly related to the allergic process, interference of these symptoms with sleep leads to daytime sleepiness and impaired quality of life. Patients miss work because of symptoms but an even greater problem is interference with work productivity, or presenteeism, which has been reported to be the biggest contributor to the total economic cost of allergic rhinitis. There has been increasing awareness that many patients with either seasonal or perennial symptoms but negative skin and in vitro tests for allergen sensitivity have local nasal allergy, diagnosable by the presence of allergen-specific IgE in their nasal secretions or a positive nasal allergen challenge or both. The pharmaceutical management of allergic rhinitis rests on symptomatic treatment with antihistamines that perhaps are more effectively administered intranasally than orally and intranasal corticosteroids. Allergen immunotherapy is very effective, even for local allergic rhinitis, and the shortcomings of subcutaneous immunotherapy of inconvenience and safety are reduced by the introduction of sublingual immunotherapy (SLIT). Use of the latter is currently somewhat limited by the lack of appropriate dosing information for SLIT liquids and the limited number of allergens for which SLIT tablets are available."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/7-1333/v1",
            "name": "Recent advances in allergic rhinitis"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent advances in allergic rhinitis </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=16746 data-id=15367 data-downloads="" data-views="" data-scholar="10.12688/f1000research.15367.1" data-recommended="" data-doi="10.12688/f1000research.15367.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/7-1333/v1/pdf?article_uuid=6b3fe346-bb91-462d-9ad0-b3f2c743ca8c" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-15367-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-15367-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-15367-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Hoyte FCL and Nelson HS. Recent advances in allergic rhinitis [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1333 (<a class=new-orange href="https://doi.org/10.12688/f1000research.15367.1" target=_blank>https://doi.org/10.12688/f1000research.15367.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-15367-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=15367 id=track-article-signin-15367 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/15367?target=/articles/7-1333/v1">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=16746 /> <input name=articleId type=hidden value=15367 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent advances in allergic rhinitis</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class=""><a href="mailto:hoytef@njhealth.org" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Flavia C. L. Hoyte</span></a><a href="https://orcid.org/0000-0002-0426-6362" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-0426-6362</div>,&nbsp;</span><span class="">Harold S. Nelson</span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class=""><a href="mailto:hoytef@njhealth.org" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Flavia C. L. Hoyte</span></a><a href="http://orcid.org/0000-0002-0426-6362" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-0426-6362</div>,&nbsp;</span><span class="">Harold S. Nelson</span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 23 Aug 2018 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.15367.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Department of Medicine, Division of Allergy/Immunology, National Jewish Health, Denver, CO, 80206, USA<br/> <p> <div class=margin-bottom> Flavia C. L. Hoyte <br/> <span>Roles: </span> Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Harold S. Nelson <br/> <span>Roles: </span> Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=37876-37177></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=37875-37176></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Allergic rhinitis affects 20 to 30% of adults in both the United States and Europe and perhaps a somewhat higher percentage of children. In addition to nasal and ocular symptoms directly related to the allergic process, interference of these symptoms with sleep leads to daytime sleepiness and impaired quality of life. Patients miss work because of symptoms but an even greater problem is interference with work productivity, or presenteeism, which has been reported to be the biggest contributor to the total economic cost of allergic rhinitis. There has been increasing awareness that many patients with either seasonal or perennial symptoms but negative skin and <i>in vitro </i>tests for allergen sensitivity have local nasal allergy, diagnosable by the presence of allergen-specific IgE in their nasal secretions or a positive nasal allergen challenge or both. The pharmaceutical management of allergic rhinitis rests on symptomatic treatment with antihistamines that perhaps are more effectively administered intranasally than orally and intranasal corticosteroids. Allergen immunotherapy is very effective, even for local allergic rhinitis, and the shortcomings of subcutaneous immunotherapy of inconvenience and safety are reduced by the introduction of sublingual immunotherapy (SLIT). Use of the latter is currently somewhat limited by the lack of appropriate dosing information for SLIT liquids and the limited number of allergens for which SLIT tablets are available. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> Allergic Rhinitis, Local nasal allergy, Immunotherapy, SCIT, SLIT </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Flavia C. L. Hoyte (<a href="mailto:hoytef@njhealth.org">hoytef@njhealth.org</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Flavia C. L. Hoyte </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> HSN has received honoraria from ALK-Abelló for speaking and consulting. He was previously a consultant to Merck. FH declares that she has no competing interests. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2018 Hoyte FCL and Nelson HS. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Hoyte FCL and Nelson HS. Recent advances in allergic rhinitis [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1333 (<a href="https://doi.org/10.12688/f1000research.15367.1" target=_blank>https://doi.org/10.12688/f1000research.15367.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 23 Aug 2018, <b>7</b>(F1000 Faculty Rev):1333 (<a href="https://doi.org/10.12688/f1000research.15367.1" target=_blank>https://doi.org/10.12688/f1000research.15367.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 23 Aug 2018, <b>7</b>(F1000 Faculty Rev):1333 (<a href="https://doi.org/10.12688/f1000research.15367.1" target=_blank>https://doi.org/10.12688/f1000research.15367.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d26898e152>Introduction</h2><p class="" id=d26898e155>Allergic rhinitis (AR) is a common condition. Estimates of its prevalence vary widely but good epidemiologic studies suggest that 20 to 30% of adults and up to 40% of children are affected<sup><a href="#ref-1">1</a></sup>. Symptoms can have significant negative impact on the patients’ quality of life, often interfere with sleep, and contribute to poor performance at work and school. In approaching the patient with rhinitis symptoms, clinicians must distinguish AR from non-AR (NAR) and nasal symptoms due to mechanical factors but not miss the presence of local nasal allergy. Treatment for more severe disease should employ anti-inflammatory as well as symptomatic medication, and allergy immunotherapy (AIT) should be strongly considered for not only its effectiveness but also its disease-modifying effects. The main challenges in AR relate to its treatment. Symptomatic and topical anti-inflammatory medication is often not fully effective, and AIT can be inconvenient and expensive, and there is much room for improvement in both forms of treatment.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d26898e165>The burden of allergic rhinitis</h2><p class="" id=d26898e168>In 2004, a mail survey in the US elicited responses from two thirds contacted<sup><a href="#ref-2">2</a></sup>. Of 19,678 adult responders, 44.3% reported nasal symptoms on at least seven days per year, 30.2% attributed these symptoms to allergies, and 20.7% reported a physician diagnosis of nasal allergies. In 2001, a two-step survey was conducted in Belgium, France, Germany, Italy, Spain, and the UK<sup><a href="#ref-3">3</a></sup>. A questionnaire was administered by telephone to 9646 adults to determine the presence of a diagnosis of or symptoms suggestive of AR. Self-awareness of AR was reported by 19%, and 13% reported a physician diagnosis of AR. All of those with positive responses were invited to a clinical center for definitive diagnosis and 725 were examined. On clinical examination, 411 out of 725 were diagnosed as having AR; 45% of these 411 had not received a previous physician diagnosis. This led to estimates of clinically confirmable AR varying from 17% in Italy to 29% in Belgium and overall 23% for the European population studied. The incidence and prevalence of AR in the children were studied in an Isle of Wight birth cohort (n = 1456) recruited in 1989<sup><a href="#ref-4">4</a></sup>. Prevalence of AR increased from 3.4% at 4 years of age to 27.3% at 18 years and was more common in boys than girls at that age.</p><p class="" id=d26898e183>In a telephone survey of 2765 adults and children (at least five years old) with a diagnosis of nasal or ocular allergies or both, 78% reported seasonal symptoms, and the peak was during the tree season (March to May) and a lesser peak occurred in the fall weed season (September)<sup><a href="#ref-5">5</a></sup>. At the peak of their or their child’s allergy season, 39% rated nasal congestion and 34% red itchy eyes as “extremely bothersome” whereas 29% said daily life was “impaired a lot”<sup><a href="#ref-5">5</a></sup>.</p><p class="" id=d26898e194>The symptoms of AR interfere with the ability to sleep, leading to daytime sleepiness and impaired quality of life<sup><a href="#ref-6">6</a></sup>. In a survey of 100 patients who had moderate/severe AR, sleep disturbances were reported by 66% of adults and 43% of children<sup><a href="#ref-7">7</a></sup>. Patients with moderate/severe AR, compared with those with mild disease, had significantly more anxiety, depression, fatigue, trouble with social interactions, and perceived signs of cognitive dysfunction<sup><a href="#ref-7">7</a></sup>. The disturbances of sleep extend to parents of children with AR, 75% of whom reported poor-quality sleep<sup><a href="#ref-8">8</a></sup>.</p><p class="" id=d26898e213>A Medline search retrieved original studies from 2005 to 2015 on the impact of AR on work productivity<sup><a href="#ref-9">9</a></sup>. Pooled analysis of studies in which the validated Work Productivity and Activity Impairment (WPAI) questionnaire had been used to collect data found an estimated 3.6% of missed work time (absenteeism) and 35.9% of work performance impairment (presenteeism) due to AR. The cost of absenteeism and presenteeism was estimated to be 3.2- to 13.5-fold higher than direct medical costs and to represent 76 to 93% of the total costs of AR<sup><a href="#ref-9">9</a></sup>. School performance is also affected by AR. In a case control study in the UK, students who were 15 to 17 years of age and currently symptomatic with AR were significantly more apt to have lower examination scores in the summer compared with the winter<sup><a href="#ref-10">10</a></sup>. The cost of AR was assessed in a representative sample of the Swedish population (18 to 65 years of age) in a report published in 2016<sup><a href="#ref-11">11</a></sup>. The mean annual direct and indirect costs because of AR were 210 Euros and 750.8 Euros, respectively. Of the total cost, 8.1% was due to absenteeism and 70.0% was due to presenteeism. The remainder was equally divided between pharmaceutical and health-care costs<sup><a href="#ref-11">11</a></sup>. The cost for the European Union countries for absenteeism and presenteeism caused by AR in untreated or inadequately treated individuals has been estimated at 55 to 151 million Euros per year<sup><a href="#ref-12">12</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d26898e244>The impact of climate change on allergic rhinitis</h2><p class="" id=d26898e247>The potential effect of climate change on the severity and extent of AR has been examined, most intensively in the case of ragweed pollen<sup><a href="#ref-13">13</a>–<a href="#ref-15">15</a></sup>. Increasing temperature and carbon dioxide exposure have been shown to increase the production of pollen from individual plants<sup><a href="#ref-13">13</a></sup>. At the same time, the increase in the number of frost-free days and the later occurrence of the first frost have been shown to correlate with longer ragweed pollen seasons and are predicted to allow ragweed to propagate further north<sup><a href="#ref-14">14</a></sup>. This is of special concern in Europe, where ragweed is established in the Rhone Valley/Burgundy in France, northern Italy, Hungary, and surrounding countries<sup><a href="#ref-15">15</a></sup>. Thus, with favorable climatic conditions, it is poised to extend into Poland, Germany, and northern France<sup><a href="#ref-15">15</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d26898e276>Rhinitis subtypes</h2><p class="" id=d26898e279>The first step in rhinitis management is determining the type(s) of rhinitis that an individual has and this can be complicated given the various phenotypes and endotypes of rhinitis. A phenotype is defined by clinical presentation, whereas an endotype is defined by underlying pathophysiologic mechanism. AR is generally differentiated from NAR by the presence of positive allergy skin testing or serum-specific IgE testing. As discussed below, there has been an increasing interest recently in local AR (LAR), which is generally diagnosed in individuals with negative serum and skin allergy tests but histories suggestive of AR, through a positive nasal allergen challenge or the identification of specific IgE (sIgE) in nasal secretions or both<sup><a href="#ref-16">16</a></sup>.</p><p class="" id=d26898e286>NAR has many subtypes, including infectious, drug-induced, gustatory, hormone-induced, atrophic, senile, and idiopathic rhinitis (IR)<sup><a href="#ref-17">17</a></sup>. Nasal symptoms can also occur as a result of structural or mechanical issues, such as choanal atresia, adenoidal hypertrophy, septal deviation, nasal tumors, or cerebrospinal fluid leaks, as well as systemic conditions, such as cystic fibrosis, primary ciliary dyskinesia, eosinophilic granulomatosis and polyangiitis, sarcoidosis, and amyloidosis. Occupational rhinitis, which can be either allergic or non-allergic, has many causative agents and can present either shortly after starting an occupation with a new antigenic exposure or following a latency period, when an individual is developing sensitization to the new antigen. Oftentimes, patients have more than one type of rhinitis, leading to a mixed phenotype or endotype or both<sup><a href="#ref-16">16</a>,<a href="#ref-18">18</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d26898e303>Natural history of allergic rhinitis</h2><p class="" id=d26898e306>The natural history of AR seems to be different from that of NAR<sup><a href="#ref-19">19</a></sup>. Young children with NAR are more likely to go into remission than their AR counterparts. In a birth cohort of over 2000 children, 73% of NAR subjects and only 12% of AR subjects went into remission between ages 4 and 8. The proportion of children with NAR decreased slightly from age 4 (8%) to age 8 (6%), whereas AR rates increased between these ages from 5% to 14%. Sensitization often precedes AR as over half of those who were sensitized but asymptomatic at age 4 developed AR by age 8<sup><a href="#ref-19">19</a></sup>. In a questionnaire-based study of adults who were 20 to 59 years old, about 23% of cases demonstrated remission of their AR symptoms within an eight-year period from 1992 to 2000, and the highest rate of remission was in the oldest age group (50 to 59 years) and the lowest rate of remission was in those with concomitant asthma. The highest incidence of new-onset AR was seen in the youngest age group (20 to 29 years)<sup><a href="#ref-20">20</a></sup>.</p><p class="" id=d26898e321>ARIA (Allergic Rhinitis and its Impact on Asthma), the World Health Organization initiative on AR, published guidelines in 2001 that shifted the paradigm from classifying AR as either seasonal AR (SAR) or perennial AR (PAR) to a classification based on frequency (persistent or intermittent, as defined below) and severity (mild or moderate/severe, based on whether or not there is impaired sleep, impairment of daily life, or troublesome symptoms)<sup><a href="#ref-21">21</a></sup>. They defined intermittent AR as affecting patients less than four days a week or less than four consecutive weeks, whereas symptoms in persistent AR lasted more than four days a week or more than four consecutive weeks<sup><a href="#ref-21">21</a></sup>. Since their initial publication, these guidelines have been updated and refined multiple times<sup><a href="#ref-22">22</a>–<a href="#ref-24">24</a></sup>.</p><p class="" id=d26898e339>Based on a study from Western Europe in which telephone interviews were performed on 9646 individuals, 726 of whom came to the clinical center for an evaluation, the investigators found a poor correlation between the seasonal/perennial terms and the intermittent/persistent classifications, respectively, and about half of the persistent subjects had SAR and half of the intermittent subjects had PAR<sup><a href="#ref-3">3</a></sup>. Another study, by Ciprandi <i>et al</i>., demonstrated that 80% of patients with AR have a mixed form of SAR and PAR, suggesting to the authors that the terms PAR and SAR are poorly reflective of real life and that intermittent and persistent may be more applicable<sup><a href="#ref-25">25</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d26898e357>Local allergic rhinitis</h2><p class="" id=d26898e360>In the last decade and a half, there has been increasing interest (particularly by a group led by Miguel Blanca in Malaga, Spain) in LAR, a term applied to patients whose allergy skin and blood testing is negative but who have a history suggestive of allergic sensitization and local evidence of atopy diagnosed by sIgE in nasal secretions or by positive nasal allergen challenge or both.</p><p class="" id=d26898e363>In a study of 50 patients with perennial NAR (PNAR), 30 with PAR, and 30 healthy controls, Rondón <i>et al</i>. found a similar nasal leukocyte-lymphocyte phenotype in the nasal lavage of PAR and PNAR patients, both of which differed from normal controls, who tended to have fewer eosinophils, total lymphocytes, and CD3<sup>+</sup>CD4<sup>+</sup> lymphocytes<sup><a href="#ref-26">26</a></sup>. A positive nasal challenge with <i>Dermatophagoides pteronyssinus</i> (D. pt.) was present in 54% of the patients with PNAR, and sIgE was identified in 22% of these individuals<sup><a href="#ref-26">26</a></sup>. In another study, in which 40 patients with LAR due to D. pt. underwent nasal challenge with D. pt., 60% had isolated and 40% had dual positive responses<sup><a href="#ref-27">27</a></sup>. Tryptase was present in the nasal secretions of 45%, elevated eosinophil chemotactic factor in 65%, and D. pt.–specific IgE in 25%. LAR to pollens has also been demonstrated by this group in a similar study comparing individuals with seasonal IR with those with pollen-induced AR. This study found similar nasal leukocyte-lymphocyte profiles in both sets of rhinitis patients, which were different from that of controls. Of the subjects with IR, 62.5% had a positive nasal allergen provocation test (NAPT) and 35% demonstrated nasal sIgE<sup><a href="#ref-28">28</a></sup>. Rondón, <i>et al</i>. also have investigated multiple NAPT (NAPT-M), in which four different allergen extracts are administered at 15-minute intervals, and have demonstrated 100% concordance with single-aeroallergen NAPTs, suggesting that this may be an efficient and cost-effective way to detect polysensitization in patients with LAR<sup><a href="#ref-29">29</a></sup>.</p><p class="" id=d26898e402>A study to determine the prevalence of LAR in a Spanish population evaluated 452 unselected adult patients with rhinitis by means of skin-prick tests, sIgE, and NAPT; they diagnosed LAR in 25.7%, AR in 63.1%, and NAR in 11.2%<sup><a href="#ref-30">30</a></sup>. A study evaluating LAR to house dust mites (HDMs), specifically evaluating a pediatric population with NAR (mean age of 11 years and median disease duration of 6.3 years), used nasal tryptase, symptoms, physiologic measures (peak nasal inspiratory flow and acoustic rhinometry), and local production of HDM-sIgE and demonstrated that LAR to HDM is rare in children. Only two (3.7%) of the 54 children showed significant change in symptoms and physiologic measures following HDM-NAPT<sup><a href="#ref-31">31</a></sup>. In contrast, a study by Bozek <i>et al</i>. looking at an elderly population (mean age of 65.81, n = 219) with undiagnosed persistent rhinitis demonstrated a rate of LAR of 21%, and D. pt. was the main sensitizing aeroallergen in those with LAR (63%)<sup><a href="#ref-32">32</a></sup>. In this study, symptom changes during NAPT were accompanied by an increase in nasal sIgE. The large, questionnaire-based studies conducted to determine the prevalence of AR in the general population could not assess the prevalence of LAR since nasal allergen challenges were not part of the protocol<sup><a href="#ref-2">2</a>,<a href="#ref-3">3</a></sup>.</p><p class="" id=d26898e427>A five-year follow-up study in 194 patients with LAR demonstrated worsening in 26.3% of the patients, and the development of atopy at five years was detected by skin-prick test or sIgE (or both) in 6.81% of LAR and 4.5% of normal control patients<sup><a href="#ref-33">33</a></sup>. At 10 years, the rate of development of systemic atopy was similar in the LAR patients and controls (9.7% versus 7.8%, <i>P</i> = 0.623). This indicates that LAR is usually a persistent condition and not a precursor to AR. The patients with LAR in this study demonstrated a significant worsening of their rhinitis over time and this was clinically relevant and associated with development of asthma<sup><a href="#ref-34">34</a></sup>. Treatment of LAR with immunotherapy is discussed in the section on immunotherapy, below.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d26898e444>Management of allergic rhinitis</h2><p class="" id=d26898e447>Management of AR continues to revolve around allergen avoidance, medications that provide symptomatic relief, anti-inflammatory therapies, and AIT. Recent advances in therapy include intranasal antihistamines and novel methods of delivery for intranasal steroids, which continue to be the mainstay of therapy for AR and now can be found over-the-counter in the US for some formulations.</p><p class="" id=d26898e450>Intranasal antihistamines, introduced in the US in 2000<sup><a href="#ref-35">35</a>,<a href="#ref-36">36</a></sup>, have broadened the landscape of intranasal medications for the treatment of AR. They have been shown to improve the total nasal symptom score (TNSS) as well as each individual nasal symptom score (INSS) for sneezing, rhinorrhea, nasal congestion, and nasal itching with faster onset and similar efficacy when compared with intranasal steroids<sup><a href="#ref-37">37</a></sup>. Intranasal antihistamines also have a faster onset than oral antihistamines and can improve all INSSs to a similar degree, except for nasal congestion, which is better controlled by nasal compared with oral antihistamines<sup><a href="#ref-38">38</a></sup>.</p><p class="" id=d26898e468>Novel delivery methods of intranasal steroids include a nasal preparation of ciclesonide, a steroid pro-drug that is converted to its active form only upon tissue delivery, introduced in aqueous form in the US in 2006<sup><a href="#ref-39">39</a></sup>; a mist formulation of fluticasone furoate, approved by the US Food and Drug Administration (FDA) in 2007<sup><a href="#ref-40">40</a></sup>; and aerosol devices using hydrofluoroalkane (HFA) propellant to deliver beclomethasone<sup><a href="#ref-41">41</a></sup> and ciclesonide<sup><a href="#ref-42">42</a></sup>, both approved by the FDA in 2012. The newest delivery mechanism for intranasal therapy is an exhalation-activated device, which currently (2017) is approved only for the delivery of fluticasone propionate to treat nasal polyps<sup><a href="#ref-43">43</a></sup> but which eventually might be approved for the treatment of AR.</p><p class="" id=d26898e491>In 2012, a combination spray containing both fluticasone propionate and azelastine hydrochloride was approved by the FDA<sup><a href="#ref-44">44</a></sup>. Aggregate data from 3398 subjects in three multicenter, randomized, double-blind, placebo- and active-controlled, parallel-group trials demonstrated a faster onset and superior efficacy as compared with each of the individual components. The onset of action was 30 minutes, and clinical improvement was observed during the first day of assessment and there was sustained benefit for the entire two-week study period<sup><a href="#ref-45">45</a></sup>. An updated consensus treatment algorithm proposes an approach to treatment that is in keeping with the ARIA guidelines and highlights a more prominent role for nasal antihistamines<sup><a href="#ref-46">46</a></sup>.</p><p class="" id=d26898e507>Although there has been a recent increase in interest among the general population regarding complementary and alternative medicine (CAM) approaches, including acupuncture, traditional Chinese medicine, and homeopathy, there is a paucity of randomized controlled studies evaluating these approaches. Acupuncture has the greatest amount of data and shows promise in smaller randomized studies<sup><a href="#ref-47">47</a>–<a href="#ref-50">50</a></sup>. Several review articles have been published on the topic of CAM and its role in treating allergic disease, including AR<sup><a href="#ref-51">51</a>–<a href="#ref-53">53</a></sup>. The consensus among these articles is that although CAM is considered to be low-risk and to have potential benefit, additional studies are needed to fully evaluate the efficacy and potential long-term benefit of these therapies<sup><a href="#ref-51">51</a>–<a href="#ref-53">53</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d26898e534>Efficacy of subcutaneous and sublingual immunotherapy in allergic rhinitis</h2><p class="" id=d26898e537>A number of systematic reviews (SRs) of subcutaneous immunotherapy (SCIT) or sublingual immunotherapy (SLIT) (or both) for AR have been conducted. A committee of the European Academy of Allergy and Clinical Immunology critically assessed these SRs for evidence of the effectiveness, safety, and cost-effectiveness of AIT for allergic rhinoconjunctivitis (ARC)<sup><a href="#ref-54">54</a></sup>. They identified 17 SRs published through the end of October 2015. These SRs suggested that, in carefully selected patients, SCIT and SLIT resulted in significant reductions in symptom scores and medication requirements for ARC with reassuring safety data. The data could not support conclusions on the relative clinical effectiveness or the cost-effectiveness of the two approaches to AIT.</p><p class="" id=d26898e544>The major recent development in AIT in the US for ARC has been the introduction of SLIT tablets containing Timothy grass, a five-grass mixture, short ragweed, or HDM (D. pt. and <i>Dermatophagoides farinae</i>) extracts. The doses of the five tablets chosen for commercial development, expressed as the content of major allergen, are listed in <a href="#T1">Table 1</a>. In most, a dose-ranging study has been performed that identified an effective dose as well as one or more less effective doses<sup><a href="#ref-55">55</a>–<a href="#ref-59">59</a></sup>. In the case of ragweed and HDMs, there were also studies that suggested that doses higher than those eventually approved carried safety concerns<sup><a href="#ref-60">60</a>,<a href="#ref-61">61</a></sup>.</p><a name=T1 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 1. Major allergen content of sublingual immunotherapy tablets selected for commercial development.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d26898e578 class=n-a></a><thead><a name=d26898e580 class=n-a></a><tr><a name=d26898e582 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d26898e584 class=n-a></a>Author</th><th align=left colspan=1 rowspan=1 valign=top><a name=d26898e587 class=n-a></a>Allergen extract</th><th align=left colspan=1 rowspan=1 valign=top><a name=d26898e590 class=n-a></a>Major allergen content</th><th align=left colspan=1 rowspan=1 valign=top><a name=d26898e593 class=n-a></a>Clinical effect versus<br class=br>placebo</th></tr></thead><tbody><a name=d26898e600 class=n-a></a><tr><a name=d26898e602 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d26898e604 class=n-a></a>Durham <i>et al</i>.<sup><a href="#ref-55">55</a></sup> (2006)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d26898e614 class=n-a></a>Timothy</td><td align=left colspan=1 rowspan=1 valign=top><a name=d26898e617 class=n-a></a>75,000 SQ = 17 μg Phl p 5</td><td align=left colspan=1 rowspan=1 valign=top><a name=d26898e620 class=n-a></a>Symptoms 21%<sup><a href="#FN1">a</a></sup><br class=br>Medications 29%<sup><a href="#FN1">a</a></sup></td></tr><tr><a name=d26898e632 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d26898e634 class=n-a></a>Didier <i>et al</i>.<sup><a href="#ref-56">56</a></sup> (2007)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d26898e644 class=n-a></a>Five grasses<br class=br>(orchard, meadow,<br class=br>perennial rye, sweet<br class=br>vernal, and Timothy)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d26898e653 class=n-a></a>300 IR = 25 μg group 5 allergen</td><td align=left colspan=1 rowspan=1 valign=top><a name=d26898e656 class=n-a></a>RTSS<br class=br>300 IR 37%<br class=br>500 IR 35%</td></tr><tr><a name=d26898e664 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d26898e666 class=n-a></a>Nolte <i>et al</i>.<sup><a href="#ref-57">57</a></sup> (2013)<br class=br>Creticos <i>et al</i>.<sup><a href="#ref-58">58</a></sup> (2013)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d26898e685 class=n-a></a>Short ragweed</td><td align=left colspan=1 rowspan=1 valign=top><a name=d26898e688 class=n-a></a>12 Amb a 1-U = 12 μg Amb a 1</td><td align=left colspan=1 rowspan=1 valign=top><a name=d26898e691 class=n-a></a>TCS<br class=br>Peak ragweed season:<br class=br>27% and 24%</td></tr><tr><a name=d26898e699 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d26898e701 class=n-a></a>Demoly <i>et al</i>.<sup><a href="#ref-59">59</a></sup><br class=br>Nolte <i>et al</i>.<sup><a href="#ref-62">62</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d26898e718 class=n-a></a>House dust mites</td><td align=left colspan=1 rowspan=1 valign=top><a name=d26898e721 class=n-a></a>12 DU = 7.5 μg each of Der p 1,<br class=br>Der f 1, Der p 2, and Der f 2</td><td align=left colspan=1 rowspan=1 valign=top><a name=d26898e726 class=n-a></a>6 DU – TCS 17.3%<br class=br>12 DU – TCS 17.7%<br class=br>12 DU – TCS 17%</td></tr><tr><a name=d26898e734 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d26898e736 class=n-a></a>Bergmann <i>et al</i>.<sup><a href="#ref-63">63</a></sup> (2014)<br class=br>Okamoto <i>et al</i>.<sup><a href="#ref-64">64</a></sup> (2016)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d26898e755 class=n-a></a>House dust mites</td><td align=left colspan=1 rowspan=1 valign=top><a name=d26898e758 class=n-a></a>300 IR = 16 μg Der p 1+ 68 μg<br class=br>Der f 1</td><td align=left colspan=1 rowspan=1 valign=top><a name=d26898e763 class=n-a></a>AAdSS<br class=br>300 IR – 17.9%<br class=br>500 IR – 20.2%<br class=br>AASS<br class=br>300 IR – 18.2%<br class=br>500 IR – 13.1%</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=d26898e781 class=n-a></a><p id=FN1> <sup>a</sup>Subjects who completed at least eight weeks of treatment before the grass pollen season. AAdSS, average adjusted symptom score (symptom score adjusted for medication use); AASS, average adjusted symptom score (adjusted for medication use); DU, developmental units; IR, index of reactivity; RTSS, rhinoconjunctivitis total symptom score; SQ, standardized quality; TCS, total combined score.</p></div></div></div><p class="" id=d26898e791>The safety data in these phase III studies of SLIT tablets have been reassuring, and no fatal or life-threatening adverse reactions have been reported<sup><a href="#ref-55">55</a>–<a href="#ref-59">59</a>,<a href="#ref-64">64</a></sup>. The use of epinephrine to treat SLIT tablet-related adverse events (TRAEs) was reported for 29 studies conducted for the registration of the ALK Timothy, short ragweed, and HDM SLIT tablets<sup><a href="#ref-65">65</a></sup>. Epinephrine was administered to treat 16 TRAEs: six systemic and 10 local application site reactions. Of the six systemic reactions, none were considered serious, five occurred with the first administration under physician observation, and one occurred on the sixth day of treatment. The occurrence of adverse reactions to short ragweed SLIT tablet was tabulated for the first 28 days of four safety or efficacy studies (or both) conducted for registration of the product<sup><a href="#ref-66">66</a></sup>. Local application site reactions were common but usually mild-moderate, of brief duration, and occurring mostly in the first week or two of treatment.</p><p class="" id=d26898e813>Five-year studies were conducted with both the Timothy<sup><a href="#ref-67">67</a></sup> and the five-grass<sup><a href="#ref-68">68</a></sup> SLIT tablets, in which treatment administered either continuously<sup><a href="#ref-67">67</a></sup> or pre- and co-seasonally<sup><a href="#ref-68">68</a></sup> was continued for three years, and the subjects were followed for two years after cessation of treatment to determine whether there was persisting benefit. With the Timothy tablet, there was 36% improvement compared to placebo in the symptom/medication score during the third year of treatment and persisting improvement of 34% and 27% the two follow-up years<sup><a href="#ref-67">67</a></sup>. With the five-grass SLIT tablet, the improvement in the symptom/medication score during the third year of treatment was 39%, and that the two follow-up years was 30% and 28%<sup><a href="#ref-68">68</a></sup>. Both results suggest that there has been modification of the underlying immunologic process by the immunotherapy. On the other hand, a study with the same dose of Timothy SLIT tablet, administered daily but for only two years, produced a clinical response that was lost one year after treatment discontinuation, suggesting that treatment of at least three years was required to produce persisting improvement<sup><a href="#ref-69">69</a></sup>.</p><p class="" id=d26898e845>Further evidence of disease modification by AIT comes from the results of a phase IV study with the Timothy grass SLIT tablet that examined the effect of three years of treatment of children ages 5 to 12 years who had documented grass-induced AR but no evidence of pre-existing asthma on careful screening<sup><a href="#ref-70">70</a></sup>. In the 812 children, three years of treatment produced persisting improvement in clinical AR during two years of follow-up. More importantly, the development of both summertime and wintertime asthma was significantly reduced in the group that had received the Timothy SLIT tablets when compared with those who had received placebo treatment (<a href="#T2">Table 2</a>). This suggests, for the first time, that immunotherapy may protect against the development of asthma caused by factors beyond the allergen used in treatment.</p><a name=T2 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 2. Reduction in the incidence of asthma in children treated 3 years with Timothy grass SLIT tablets with 2-year follow-up<sup><a href="#ref-70">70</a></sup>.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d26898e870 class=n-a></a><thead><a name=d26898e872 class=n-a></a><tr><a name=d26898e874 class=n-a></a><th colspan=1 rowspan=1><a name=d26898e876 class=n-a></a></th><th align=left colspan=1 rowspan=1 valign=top><a name=d26898e878 class=n-a></a>Year 1</th><th align=left colspan=1 rowspan=1 valign=top><a name=d26898e881 class=n-a></a>Year 2</th><th align=left colspan=1 rowspan=1 valign=top><a name=d26898e884 class=n-a></a>Year 3</th><th align=left colspan=1 rowspan=1 valign=top><a name=d26898e887 class=n-a></a>Year 4</th><th align=left colspan=1 rowspan=1 valign=top><a name=d26898e891 class=n-a></a>Year 5</th></tr></thead><tbody><a name=d26898e896 class=n-a></a><tr><a name=d26898e898 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d26898e900 class=n-a></a>Summer visits</td><td colspan=1 rowspan=1><a name=d26898e903 class=n-a></a></td><td colspan=1 rowspan=1><a name=d26898e905 class=n-a></a></td><td colspan=1 rowspan=1><a name=d26898e907 class=n-a></a></td><td colspan=1 rowspan=1><a name=d26898e909 class=n-a></a></td><td colspan=1 rowspan=1><a name=d26898e912 class=n-a></a></td></tr><tr><a name=d26898e915 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d26898e917 class=n-a></a>SQ grass versus<br class=br>placebo SLIT<br class=br>tablet</td><td align=left colspan=1 rowspan=1 valign=top><a name=d26898e924 class=n-a></a>OR = 0.57<br class=br><i>P</i> = 0.067</td><td align=left colspan=1 rowspan=1 valign=top><a name=d26898e931 class=n-a></a>OR = 0.40<br class=br><i>P</i> = 0.0014</td><td align=left colspan=1 rowspan=1 valign=top><a name=d26898e938 class=n-a></a>OR = 0.54<br class=br><i>P</i> = 0.048</td><td align=left colspan=1 rowspan=1 valign=top><a name=d26898e945 class=n-a></a>OR = 0.37<br class=br><i>P</i> = 0.00064</td><td align=left colspan=1 rowspan=1 valign=top><a name=d26898e953 class=n-a></a>OR = −0.55<br class=br><i>P</i> = 0.042</td></tr><tr><a name=d26898e961 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d26898e963 class=n-a></a>Winter visits</td><td colspan=1 rowspan=1><a name=d26898e966 class=n-a></a></td><td colspan=1 rowspan=1><a name=d26898e968 class=n-a></a></td><td colspan=1 rowspan=1><a name=d26898e970 class=n-a></a></td><td colspan=1 rowspan=1><a name=d26898e972 class=n-a></a></td><td colspan=1 rowspan=1><a name=d26898e975 class=n-a></a></td></tr><tr><a name=d26898e978 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d26898e980 class=n-a></a>SQ grass versus<br class=br>placebo SLIT<br class=br>tablet</td><td align=left colspan=1 rowspan=1 valign=top><a name=d26898e987 class=n-a></a>OR = 1.69<br class=br><i>P</i> = 0.13</td><td align=left colspan=1 rowspan=1 valign=top><a name=d26898e994 class=n-a></a>OR = 1.22<br class=br><i>P</i> = 0.53</td><td align=left colspan=1 rowspan=1 valign=top><a name=d26898e1001 class=n-a></a>OR = 0.54<br class=br><i>P</i> = 0.059</td><td align=left colspan=1 rowspan=1 valign=top><a name=d26898e1008 class=n-a></a>OR 0.44<br class=br><i>P</i> = 0.016</td><td align=left colspan=1 rowspan=1 valign=top><a name=d26898e1016 class=n-a></a>OR = 0.37<br class=br><i>P</i> = 0.0027</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=d26898e1028 class=n-a></a><p id=d26898e1030> OR, odds risk; SLIT, sublingual immunotherapy; SQ, standardized quality.</p></div></div></div><p class="" id=d26898e1036>Use of SLIT with liquid preparations in the US has been limited by the lack of an FDA-approved allergen extract for SLIT, although there is some “off label” use<sup><a href="#ref-71">71</a>,<a href="#ref-72">72</a></sup>. In Europe, SLIT with liquid preparations is widely employed. However, studies of extracts from three major European extract manufacturers suggested widely varying doses, some of which are well below those that have proven to be necessary for clinical efficacy in dose-ranging studies of SLIT tablets<sup><a href="#ref-73">73</a></sup>. The same marked heterogeneity of dosing was found in a study of five commercial HDM liquid SLIT preparations in Spain<sup><a href="#ref-74">74</a></sup>. The ranges in doses recommended by the five companies were 130-fold for Der p 1, 129-fold for Der f 1, and 115-fold for group 2 allergens. An additional problem with the use of SLIT liquid extracts in the US, where multiple-allergen mixes are routinely employed in SCIT, is the lack of evidence for efficacy of mixtures of more than two unrelated extracts<sup><a href="#ref-75">75</a></sup>.</p><p class="" id=d26898e1058>In comparison with SLIT, there have been far fewer recent studies with SCIT. Most have reported on the development of products that offer greater convenience and safety over the use of SCIT with the currently available products. For the most part, these products are still under development. The exceptions are the allergoids, extracts modified by treatment with aldehydes, that in some cases have shown markedly reduced allergenicity, allowing very rapid build-up in dosing<sup><a href="#ref-76">76</a></sup>.</p><p class="" id=d26898e1065>AIT has also been used in patients with LAR (see section on LAR above). Thirty-six subjects with perennial symptoms and positive NAPTs to D. pt. received SCIT with D. pt. extract. At the end of 24 months, daily combined symptom/medication scores were reduced 42% compared with placebo (<i>P</i> = 0.001) and NAPT after one year showed markedly increased tolerance for D. pt. allergen<sup><a href="#ref-77">77</a></sup>. The same group also conducted a two-year trial of SCIT with a Timothy grass allergoid extract in 56 LAR subjects with positive NAPT to Timothy<sup><a href="#ref-78">78</a></sup>. In the first grass pollen season, after about six months of SCIT, combined symptom medication scores were reduced 54%. The efficacy of SCIT in pollen-induced LAR was also demonstrated in a two-year study in 28 subjects with birch sensitivity<sup><a href="#ref-79">79</a></sup>. The efficacy of SLIT in patients with LAR has not been reported.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d26898e1086>Concluding remarks</h2><p class="" id=d26898e1089>There is no question that AR is a very common and often very burdensome disease. It can be classified as seasonal or perennial, which has the attraction of directing attention to the relevant aeroallergen, or as intermittent and persistent and mild or moderate/severe that reflects more the burden of the disease on the patient. It is important not to confuse NAR with AR but also not to miss LAR if indeed it is as common as reports indicate. There is a need for more effective forms of symptomatic therapy<sup><a href="#ref-80">80</a></sup>. There also is a need for new approaches to AIT that overcome the factors of safety and inconvenience with SCIT but also the limited number of allergens with established dosing with SLIT. Both of these forms of AIT involve several years of treatment to produce lasting results and in many patients this leads to poor adherence with the treatment program<sup><a href="#ref-81">81</a></sup>. Forms of AIT that require far fewer treatments over shorter periods of time are sorely needed.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d26898e1103>Abbreviations</h2><p class="" id=d26898e1106>AIT, allergy immunotherapy; AR, allergic rhinitis; ARC, allergic rhinoconjunctivitis; ARIA, Allergic Rhinitis and its Impact on Asthma; CAM, complementary and alternative medicine; D. pt., <i>Dermatophagoides pteronyssinus</i>; FDA, US Food and Drug Administration; HDM, house dust mite; INSS, individual nasal symptom score; IR, idiopathic rhinitis; LAR, local allergic rhinitis; NAPT, nasal allergen provocation test; NAR, non-allergic rhinitis; PAR, perennial allergic rhinitis; PNAR, perennial non-allergic rhinitis; SAR, seasonal allergic rhinitis; SCIT, subcutaneous immunotherapy; sIgE, specific IgE; SLIT, sublingual immunotherapy; SR, systematic review; TRAE, treatment-related adverse event</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d26898e1 class=n-a></a><h2 class=main-title id=d27146>Grant information</h2><p>The author(s) declared that no grants were involved in supporting this work.</p></div><div class=back-section><a name=d26898e1116 class=n-a></a><h2 class=main-title id=d26898e1118>Acknowledgments</h2><p class="" id=d26898e1121>The authors wish to thank Diedre Versluis and Lien Hang for their assistance in preparing the manuscript.</p></div><div class=back-section><a name=d26898e1125 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d27396>References</h2><div class="section ref-list"><a name=d26898e1125 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726305047"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d26898e1132 class=n-a></a>Meltzer EO: Allergic Rhinitis: Burden of Illness, Quality of Life, Comorbidities, and Control. <i>Immunol Allergy Clin North Am.</i> 2016; <b>36</b>(2): 235–48. <a target=xrefwindow id=d26898e1140 href="http://www.ncbi.nlm.nih.gov/pubmed/27083099">PubMed Abstract </a> | <a target=xrefwindow id=d26898e1143 href="http://dx.doi.org/10.1016/j.iac.2015.12.002">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726305047">F1000 Recommendation</a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d26898e1156 class=n-a></a>Nathan RA, Meltzer EO, Derebery J, <i> et al.</i>: The prevalence of nasal symptoms attributed to allergies in the United States: findings from the burden of rhinitis in an America survey. <i>Allergy Asthma Proc.</i> 2008; <b>29</b>(6): 600–8. <a target=xrefwindow id=d26898e1167 href="http://www.ncbi.nlm.nih.gov/pubmed/19173786">PubMed Abstract </a> | <a target=xrefwindow id=d26898e1170 href="http://dx.doi.org/10.2500/aap.2008.29.3179">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d26898e1179 class=n-a></a>Bauchau V, Durham SR: Prevalence and rate of diagnosis of allergic rhinitis in Europe. <i>Eur Respir J.</i> 2004; <b>24</b>(5): 758–64. <a target=xrefwindow id=d26898e1187 href="http://www.ncbi.nlm.nih.gov/pubmed/15516669">PubMed Abstract </a> | <a target=xrefwindow id=d26898e1190 href="http://dx.doi.org/10.1183/09031936.04.00013904">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d26898e1199 class=n-a></a>Kurukulaaratchy RJ, Karmaus W, Raza A, <i> et al.</i>: The influence of gender and atopy on the natural history of rhinitis in the first 18 years of life. <i>Clin Exp Allergy.</i> 2011; <b>41</b>(6): 851–9. <a target=xrefwindow id=d26898e1210 href="http://www.ncbi.nlm.nih.gov/pubmed/21561494">PubMed Abstract </a> | <a target=xrefwindow id=d26898e1213 href="http://dx.doi.org/10.1111/j.1365-2222.2011.03765.x">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d26898e1222 class=n-a></a>Bielory L, Skoner DP, Blaiss MS, <i> et al.</i>: Ocular and nasal allergy symptom burden in America: the Allergies, Immunotherapy, and RhinoconjunctivitiS (AIRS) surveys. <i>Allergy Asthma Proc.</i> 2014; <b>35</b>(3): 211–8. <a target=xrefwindow id=d26898e1233 href="http://www.ncbi.nlm.nih.gov/pubmed/24801463">PubMed Abstract </a> | <a target=xrefwindow id=d26898e1236 href="http://dx.doi.org/10.2500/aap.2014.35.3750">Publisher Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d26898e1246 class=n-a></a>Stuck BA, Czajkowski J, Hagner AE, <i> et al.</i>: Changes in daytime sleepiness, quality of life, and objective sleep patterns in seasonal allergic rhinitis: a controlled clinical trial. <i>J Allergy Clin Immunol.</i> 2004; <b>113</b>(4): 663–8. <a target=xrefwindow id=d26898e1257 href="http://www.ncbi.nlm.nih.gov/pubmed/15100670">PubMed Abstract </a> | <a target=xrefwindow id=d26898e1260 href="http://dx.doi.org/10.1016/j.jaci.2003.12.589">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733806169"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d26898e1269 class=n-a></a>Dass K, Petrusan AJ, Beaumont J, <i> et al.</i>: Assessment of sleep disturbance in children with allergic rhinitis. <i>Ann Allergy Asthma Immunol.</i> 2017; <b>118</b>(4): 505–6. <a target=xrefwindow id=d26898e1280 href="http://www.ncbi.nlm.nih.gov/pubmed/28143682">PubMed Abstract </a> | <a target=xrefwindow id=d26898e1283 href="http://dx.doi.org/10.1016/j.anai.2016.12.022">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733806169">F1000 Recommendation</a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d26898e1296 class=n-a></a>Ridolo E, Caffarelli C, Olivieri E, <i> et al.</i>: Quality of sleep in allergic children and their parents. <i>Allergol Immunopathol (Madr).</i> 2015; <b>43</b>(2): 180–4. <a target=xrefwindow id=d26898e1307 href="http://www.ncbi.nlm.nih.gov/pubmed/24948186">PubMed Abstract </a> | <a target=xrefwindow id=d26898e1310 href="http://dx.doi.org/10.1016/j.aller.2014.01.004">Publisher Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/731967190"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d26898e1319 class=n-a></a>Vandenplas O, Vinnikov D, Blanc PD, <i> et al.</i>: Impact of Rhinitis on Work Productivity: A Systematic Review. <i>J Allergy Clin Immunol Pract.</i> 2018; <b>6</b>(4): 1274–1286.e9. <a target=xrefwindow id=d26898e1330 href="http://www.ncbi.nlm.nih.gov/pubmed/29017832">PubMed Abstract </a> | <a target=xrefwindow id=d26898e1333 href="http://dx.doi.org/10.1016/j.jaip.2017.09.002">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/731967190">F1000 Recommendation</a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d26898e1346 class=n-a></a>Walker S, Khan-Wasti S, Fletcher M, <i> et al.</i>: Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: case-control study. <i>J Allergy Clin Immunol.</i> 2007; <b>120</b>(2): 381–7. <a target=xrefwindow id=d26898e1357 href="http://www.ncbi.nlm.nih.gov/pubmed/17560637">PubMed Abstract </a> | <a target=xrefwindow id=d26898e1360 href="http://dx.doi.org/10.1016/j.jaci.2007.03.034">Publisher Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726122375"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d26898e1369 class=n-a></a>Cardell LO, Olsson P, Andersson M, <i> et al.</i>: TOTALL: high cost of allergic rhinitis-a national Swedish population-based questionnaire study. <i>NPJ Prim Care Respir Med.</i> 2016; <b>26</b>: 15082. <a target=xrefwindow id=d26898e1380 href="http://www.ncbi.nlm.nih.gov/pubmed/26845513">PubMed Abstract </a> | <a target=xrefwindow id=d26898e1383 href="http://dx.doi.org/10.1038/npjpcrm.2015.82">Publisher Full Text </a> | <a target=xrefwindow id=d26898e1387 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4741287">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726122375">F1000 Recommendation</a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d26898e1401 class=n-a></a>Zuberbier T, Lötvall J, Simoens S, <i> et al.</i>: Economic burden of inadequate management of allergic diseases in the European Union: A GA<sup>2</sup> LEN review. <i>Allergy.</i> 2014; <b>69</b>(10): 1275–9. <a target=xrefwindow id=d26898e1415 href="http://www.ncbi.nlm.nih.gov/pubmed/24965386">PubMed Abstract </a> | <a target=xrefwindow id=d26898e1419 href="http://dx.doi.org/10.1111/all.12470">Publisher Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d26898e1428 class=n-a></a>Smith M, Cecchi L, Skjøth CA, <i> et al.</i>: Common ragweed: a threat to environmental health in Europe. <i>Environ Int.</i> 2013; <b>61</b>: 115–26. <a target=xrefwindow id=d26898e1439 href="http://www.ncbi.nlm.nih.gov/pubmed/24140540">PubMed Abstract </a> | <a target=xrefwindow id=d26898e1442 href="http://dx.doi.org/10.1016/j.envint.2013.08.005">Publisher Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d26898e1451 class=n-a></a>Ziska L, Knowlton K, Rogers C, <i> et al.</i>: Recent warming by latitude associated with increased length of ragweed pollen season in central North America. <i>Proc Natl Acad Sci U S A.</i> 2011; <b>108</b>(10): 4248–51. <a target=xrefwindow id=d26898e1462 href="http://www.ncbi.nlm.nih.gov/pubmed/21368130">PubMed Abstract </a> | <a target=xrefwindow id=d26898e1465 href="http://dx.doi.org/10.1073/pnas.1014107108">Publisher Full Text </a> | <a target=xrefwindow id=d26898e1469 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3053965">Free Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726669347"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d26898e1478 class=n-a></a>Lake IR, Jones NR, Agnew M, <i> et al.</i>: Climate Change and Future Pollen Allergy in Europe. <i>Environ Health Perspect.</i> 2017; <b>125</b>(3): 385–91. <a target=xrefwindow id=d26898e1489 href="http://www.ncbi.nlm.nih.gov/pubmed/27557093">PubMed Abstract </a> | <a target=xrefwindow id=d26898e1492 href="http://dx.doi.org/10.1289/EHP173">Publisher Full Text </a> | <a target=xrefwindow id=d26898e1496 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5332176">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726669347">F1000 Recommendation</a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d26898e1509 class=n-a></a>Papadopoulos NG, Bernstein JA, Demoly P, <i> et al.</i>: Phenotypes and endotypes of rhinitis and their impact on management: a PRACTALL report. <i>Allergy.</i> 2015; <b>70</b>(5): 474–94. <a target=xrefwindow id=d26898e1520 href="http://www.ncbi.nlm.nih.gov/pubmed/25620381">PubMed Abstract </a> | <a target=xrefwindow id=d26898e1523 href="http://dx.doi.org/10.1111/all.12573">Publisher Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727586976"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d26898e1532 class=n-a></a>Hellings PW, Klimek L, Cingi C, <i> et al.</i>: Non-allergic rhinitis: Position paper of the European Academy of Allergy and Clinical Immunology. <i>Allergy.</i> 2017; <b>72</b>(11): 1657–65. <a target=xrefwindow id=d26898e1543 href="http://www.ncbi.nlm.nih.gov/pubmed/28474799">PubMed Abstract </a> | <a target=xrefwindow id=d26898e1546 href="http://dx.doi.org/10.1111/all.13200">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727586976">F1000 Recommendation</a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/728664255"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d26898e1560 class=n-a></a>Papadopoulos NG, Guibas GV: Rhinitis Subtypes, Endotypes, and Definitions. <i>Immunol Allergy Clin North Am.</i> 2016; <b>36</b>(2): 215–33. <a target=xrefwindow id=d26898e1568 href="http://www.ncbi.nlm.nih.gov/pubmed/27083098">PubMed Abstract </a> | <a target=xrefwindow id=d26898e1571 href="http://dx.doi.org/10.1016/j.iac.2015.12.001">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/728664255">F1000 Recommendation</a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d26898e1584 class=n-a></a>Westman M, Stjärne P, Asarnoj A, <i> et al.</i>: Natural course and comorbidities of allergic and nonallergic rhinitis in children. <i>J Allergy Clin Immunol.</i> 2012; <b>129</b>(2): 403–8. <a target=xrefwindow id=d26898e1595 href="http://www.ncbi.nlm.nih.gov/pubmed/22056609">PubMed Abstract </a> | <a target=xrefwindow id=d26898e1598 href="http://dx.doi.org/10.1016/j.jaci.2011.09.036">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d26898e1607 class=n-a></a>Nihlén U, Greiff L, Montnémery P, <i> et al.</i>: Incidence and remission of self-reported allergic rhinitis symptoms in adults. <i>Allergy.</i> 2006; <b>61</b>(11): 1299–304. <a target=xrefwindow id=d26898e1618 href="http://www.ncbi.nlm.nih.gov/pubmed/17002705">PubMed Abstract </a> | <a target=xrefwindow id=d26898e1621 href="http://dx.doi.org/10.1111/j.1398-9995.2006.01166.x">Publisher Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d26898e1630 class=n-a></a>Bousquet J, Van Cauwenberge P, Khaltaev N: Allergic rhinitis and its impact on asthma. <i>J Allergy Clin Immunol.</i> 2001; <b>108</b>(5 Suppl): S147–334. <a target=xrefwindow id=d26898e1638 href="http://www.ncbi.nlm.nih.gov/pubmed/11707753">PubMed Abstract </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d26898e1647 class=n-a></a>Bousquet J, Khaltaev N, Cruz AA, <i> et al.</i>: Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). <i>Allergy.</i> 2008; <b>63 Suppl 86</b>: 8–160. <a target=xrefwindow id=d26898e1658 href="http://www.ncbi.nlm.nih.gov/pubmed/18331513">PubMed Abstract </a> | <a target=xrefwindow id=d26898e1661 href="http://dx.doi.org/10.1111/j.1398-9995.2007.01620.x">Publisher Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d26898e1670 class=n-a></a>Brozek JL, Bousquet J, Baena-Cagnani CE, <i> et al.</i>: Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. <i>J Allergy Clin Immunol.</i> 2010; <b>126</b>(3): 466–76. <a target=xrefwindow id=d26898e1681 href="http://www.ncbi.nlm.nih.gov/pubmed/20816182">PubMed Abstract </a> | <a target=xrefwindow id=d26898e1684 href="http://dx.doi.org/10.1016/j.jaci.2010.06.047">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d26898e1694 class=n-a></a>Brożek JL, Bousquet J, Agache I, <i> et al.</i>: Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision. <i>J Allergy Clin Immunol.</i> 2017; <b>140</b>(4): 950–8. <a target=xrefwindow id=d26898e1705 href="http://www.ncbi.nlm.nih.gov/pubmed/28602936">PubMed Abstract </a> | <a target=xrefwindow id=d26898e1708 href="http://dx.doi.org/10.1016/j.jaci.2017.03.050">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d26898e1717 class=n-a></a>Ciprandi G, Cirillo I, Vizzaccaro A, <i> et al.</i>: Seasonal and perennial allergic rhinitis: Is this classification adherent to real life? <i>Allergy.</i> 2005; <b>60</b>(7): 882–7. <a target=xrefwindow id=d26898e1728 href="http://www.ncbi.nlm.nih.gov/pubmed/15932377">PubMed Abstract </a> | <a target=xrefwindow id=d26898e1731 href="http://dx.doi.org/10.1111/j.1398-9995.2005.00602.x">Publisher Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d26898e1740 class=n-a></a>Rondón C, Romero JJ, López S, <i> et al.</i>: Local IgE production and positive nasal provocation test in patients with persistent nonallergic rhinitis. <i>J Allergy Clin Immunol.</i> 2007; <b>119</b>(4): 899–905. <a target=xrefwindow id=d26898e1751 href="http://www.ncbi.nlm.nih.gov/pubmed/17337294">PubMed Abstract </a> | <a target=xrefwindow id=d26898e1754 href="http://dx.doi.org/10.1016/j.jaci.2007.01.006">Publisher Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d26898e1763 class=n-a></a>López S, Rondón C, Torres MJ, <i> et al.</i>: Immediate and dual response to nasal challenge with <i>Dermatophagoides pteronyssinus</i> in local allergic rhinitis. <i>Clin Exp Allergy.</i> 2010; <b>40</b>(7): 1007–14. <a target=xrefwindow id=d26898e1777 href="http://www.ncbi.nlm.nih.gov/pubmed/20337651">PubMed Abstract </a> | <a target=xrefwindow id=d26898e1781 href="http://dx.doi.org/10.1111/j.1365-2222.2010.03492.x">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d26898e1790 class=n-a></a>Rondón C, Doña I, López S, <i> et al.</i>: Seasonal idiopathic rhinitis with local inflammatory response and specific IgE in absence of systemic response. <i>Allergy.</i> 2008; <b>63</b>(10): 1352–8. <a target=xrefwindow id=d26898e1801 href="http://www.ncbi.nlm.nih.gov/pubmed/18782115">PubMed Abstract </a> | <a target=xrefwindow id=d26898e1804 href="http://dx.doi.org/10.1111/j.1398-9995.2008.01695.x">Publisher Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d26898e1813 class=n-a></a>Rondón C, Campo P, Herrera R, <i> et al.</i>: Nasal allergen provocation test with multiple aeroallergens detects polysensitization in local allergic rhinitis. <i>J Allergy Clin Immunol.</i> 2011; <b>128</b>(6): 1192–7. <a target=xrefwindow id=d26898e1824 href="http://www.ncbi.nlm.nih.gov/pubmed/21783237">PubMed Abstract </a> | <a target=xrefwindow id=d26898e1827 href="http://dx.doi.org/10.1016/j.jaci.2011.06.012">Publisher Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d26898e1837 class=n-a></a>Rondón C, Campo P, Galindo L, <i> et al.</i>: Prevalence and clinical relevance of local allergic rhinitis. <i>Allergy.</i> 2012; <b>67</b>(10): 1282–8. <a target=xrefwindow id=d26898e1848 href="http://www.ncbi.nlm.nih.gov/pubmed/22913574">PubMed Abstract </a> | <a target=xrefwindow id=d26898e1851 href="http://dx.doi.org/10.1111/all.12002">Publisher Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d26898e1860 class=n-a></a>Buntarickpornpan P, Veskitkul J, Pacharn P, <i> et al.</i>: The proportion of local allergic rhinitis to <i>Dermatophagoides pteronyssinus</i> in children. <i>Pediatr Allergy Immunol.</i> 2016; <b>27</b>(6): 574–9. <a target=xrefwindow id=d26898e1874 href="http://www.ncbi.nlm.nih.gov/pubmed/27289005">PubMed Abstract </a> | <a target=xrefwindow id=d26898e1878 href="http://dx.doi.org/10.1111/pai.12606">Publisher Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725381200"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d26898e1887 class=n-a></a>Bozek A, Ignasiak B, Kasperska-Zajac A, <i> et al.</i>: Local allergic rhinitis in elderly patients. <i>Ann Allergy Asthma Immunol.</i> 2015; <b>114</b>(3): 199–202. <a target=xrefwindow id=d26898e1898 href="http://www.ncbi.nlm.nih.gov/pubmed/25744906">PubMed Abstract </a> | <a target=xrefwindow id=d26898e1901 href="http://dx.doi.org/10.1016/j.anai.2014.12.013">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725381200">F1000 Recommendation</a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d26898e1914 class=n-a></a>Rondón C, Campo P, Zambonino MA, <i> et al.</i>: Follow-up study in local allergic rhinitis shows a consistent entity not evolving to systemic allergic rhinitis. <i>J Allergy Clin Immunol.</i> 2014; <b>133</b>(4): 1026–31. <a target=xrefwindow id=d26898e1925 href="http://www.ncbi.nlm.nih.gov/pubmed/24332860">PubMed Abstract </a> | <a target=xrefwindow id=d26898e1928 href="http://dx.doi.org/10.1016/j.jaci.2013.10.034">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/729083545"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d26898e1937 class=n-a></a>Rondon C, Campo P, Eguiluz-Gracia I, <i> et al.</i>: Local allergic rhinitis is an independent rhinitis phenotype: The results of a 10-year follow-up study. <i>Allergy.</i> 2018; <b>73</b>(2): 470–8. <a target=xrefwindow id=d26898e1948 href="http://www.ncbi.nlm.nih.gov/pubmed/28833265">PubMed Abstract </a> | <a target=xrefwindow id=d26898e1951 href="http://dx.doi.org/10.1111/all.13272">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/729083545">F1000 Recommendation</a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d26898e1964 class=n-a></a><a target=xrefwindow id=d26898e1965><a target=xrefwindow id=d26898e1965 href="https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/20114S006_Astelin.cfmsimple"> https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/20114S006_Astelin.cfm</a></a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d26898e1975 class=n-a></a><a target=xrefwindow id=d26898e1976><a target=xrefwindow id=d26898e1976 href="https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/021861s000TOC.cfmsimple"> https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/021861s000TOC.cfm</a></a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d26898e1985 class=n-a></a>Kaliner MA, Storms W, Tilles S, <i> et al.</i>: Comparison of olopatadine 0.6% nasal spray versus fluticasone propionate 50 microg in the treatment of seasonal allergic rhinitis. <i>Allergy Asthma Proc.</i> 2009; <b>30</b>(3): 255–62. <a target=xrefwindow id=d26898e1996 href="http://www.ncbi.nlm.nih.gov/pubmed/19549426">PubMed Abstract </a> | <a target=xrefwindow id=d26898e1999 href="http://dx.doi.org/10.2500/aap.2009.30.3232">Publisher Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d26898e2008 class=n-a></a>Berger W, Hampel F Jr, Bernstein J, <i> et al.</i>: Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitis. <i>Ann Allergy Asthma Immunol.</i> 2006; <b>97</b>(3): 375–81. <a target=xrefwindow id=d26898e2019 href="http://www.ncbi.nlm.nih.gov/pubmed/17042145">PubMed Abstract </a> | <a target=xrefwindow id=d26898e2022 href="http://dx.doi.org/10.1016/S1081-1206(10)60804-6">Publisher Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d26898e2031 class=n-a></a>Drug Approval Package: Omnaris (Ciclesonide) NDA #022004 [Internet]. U.S. Food and Drug Administration. 2006. <a target=xrefwindow id=d26898e2033 href="https://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/022004s000TOC.cfm">Reference Source</a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d26898e2042 class=n-a></a>Drug Approval Package: Veramyst (fluticasone furoate) NDA #022051 [Internet]. U.S. Food and Drug Administration. 2007. <a target=xrefwindow id=d26898e2044 href="https://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/022051_veramyst_toc.cfm">Reference Source</a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d26898e2053 class=n-a></a>Drug Approval Package: Zetonna (ciclesonide) NDA #202129 [Internet]. U.S. Food and Drug Administration. 2012. <a target=xrefwindow id=d26898e2055 href="https://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/202129_zetonna_toc.cfm">Reference Source</a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d26898e2065 class=n-a></a>Drug Approval Package: Qnasl (beclomethasone dipropionate) NDA #202813 [Internet]. U.S. Food and Drug Administration. 2012. <a target=xrefwindow id=d26898e2067 href="https://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/202813_qnasl_toc.cfm">Reference Source</a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d26898e2076 class=n-a></a>Drug Approval Package: Dymista (azelastine hydrochloride and fluticasone proprionate) NDA #202236 [Internet]. U.S. Food and Drug Administration. 2012. <a target=xrefwindow id=d26898e2078 href="https://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/202236_dymista_toc.cfm">Reference Source</a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d26898e2087 class=n-a></a>Xhance (fluticasone propionate) Nasal Spray [Internet]. U.S. Food and Drug Administration. 2017. <a target=xrefwindow id=d26898e2089 href="https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/209022Orig1s000_revTOC.cfm">Reference Source</a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718723596"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d26898e2098 class=n-a></a>Carr W, Bernstein J, Lieberman P, <i> et al.</i>: A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis. <i>J Allergy Clin Immunol.</i> 2012; <b>129</b>(5): 1282–1289.e10. <a target=xrefwindow id=d26898e2109 href="http://www.ncbi.nlm.nih.gov/pubmed/22418065">PubMed Abstract </a> | <a target=xrefwindow id=d26898e2112 href="http://dx.doi.org/10.1016/j.jaci.2012.01.077">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718723596">F1000 Recommendation</a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d26898e2125 class=n-a></a>Hoyte FC, Meltzer EO, Ostrom NK, <i> et al.</i>: Recommendations for the pharmacologic management of allergic rhinitis. <i>Allergy Asthma Proc.</i> 2014; <b>35 Suppl 1</b>: S20–7. <a target=xrefwindow id=d26898e2136 href="http://www.ncbi.nlm.nih.gov/pubmed/25582158">PubMed Abstract </a> | <a target=xrefwindow id=d26898e2139 href="http://dx.doi.org/10.2500/aap.2014.35.3761">Publisher Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717980123"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d26898e2148 class=n-a></a>Brinkhaus B, Ortiz M, Witt CM, <i> et al.</i>: Acupuncture in patients with seasonal allergic rhinitis: a randomized trial. <i>Ann Intern Med.</i> 2013; <b>158</b>(4): 225–34. <a target=xrefwindow id=d26898e2159 href="http://www.ncbi.nlm.nih.gov/pubmed/23420231">PubMed Abstract </a> | <a target=xrefwindow id=d26898e2162 href="http://dx.doi.org/10.7326/0003-4819-158-4-201302190-00002">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717980123">F1000 Recommendation</a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733806174"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d26898e2176 class=n-a></a>Adam D, Grabenhenrich L, Ortiz M, <i> et al.</i>: Impact of acupuncture on antihistamine use in patients suffering seasonal allergic rhinitis: secondary analysis of results from a randomised controlled trial. <i>Acupunct Med.</i> 2018; <b>36</b>(3): 139–45. <a target=xrefwindow id=d26898e2187 href="http://www.ncbi.nlm.nih.gov/pubmed/29440045">PubMed Abstract </a> | <a target=xrefwindow id=d26898e2190 href="http://dx.doi.org/10.1136/acupmed-2017-011382">Publisher Full Text </a> | <a target=xrefwindow id=d26898e2194 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6029641">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733806174">F1000 Recommendation</a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d26898e2207 class=n-a></a>Xue CC, Zhang AL, Zhang CS, <i> et al.</i>: Acupuncture for seasonal allergic rhinitis: a randomized controlled trial. <i>Ann Allergy Asthma Immunol.</i> 2015; <b>115</b>(4): 317–324.e1. <a target=xrefwindow id=d26898e2218 href="http://www.ncbi.nlm.nih.gov/pubmed/26073163">PubMed Abstract </a> | <a target=xrefwindow id=d26898e2221 href="http://dx.doi.org/10.1016/j.anai.2015.05.017">Publisher Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d26898e2230 class=n-a></a>Taw MB, Reddy WD, Omole FS, <i> et al.</i>: Acupuncture and allergic rhinitis. <i>Curr Opin Otolaryngol Head Neck Surg.</i> 2015; <b>23</b>(3): 216–20. <a target=xrefwindow id=d26898e2241 href="http://www.ncbi.nlm.nih.gov/pubmed/25943957">PubMed Abstract </a> | <a target=xrefwindow id=d26898e2244 href="http://dx.doi.org/10.1097/MOO.0000000000000161">Publisher Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/730038471"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d26898e2253 class=n-a></a>Qiu J, Grine K: Complementary and Alternative Treatment for Allergic Conditions. <i>Prim Care.</i> 2016; <b>43</b>(3): 519–26. <a target=xrefwindow id=d26898e2261 href="http://www.ncbi.nlm.nih.gov/pubmed/27545740">PubMed Abstract </a> | <a target=xrefwindow id=d26898e2264 href="http://dx.doi.org/10.1016/j.pop.2016.04.012">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/730038471">F1000 Recommendation</a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d26898e2277 class=n-a></a>Kern J, Bielory L: Complementary and alternative therapy (CAM) in the treatment of allergic rhinitis. <i>Curr Allergy Asthma Rep.</i> 2014; <b>14</b>(12): 479. <a target=xrefwindow id=d26898e2285 href="http://www.ncbi.nlm.nih.gov/pubmed/25269403">PubMed Abstract </a> | <a target=xrefwindow id=d26898e2288 href="http://dx.doi.org/10.1007/s11882-014-0479-8">Publisher Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726305043"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d26898e2297 class=n-a></a>Surda P, Fokkens WJ: Novel, Alternative, and Controversial Therapies of Rhinitis. <i>Immunol Allergy Clin North Am.</i> 2016; <b>36</b>(2): 401–23. <a target=xrefwindow id=d26898e2305 href="http://www.ncbi.nlm.nih.gov/pubmed/27083111">PubMed Abstract </a> | <a target=xrefwindow id=d26898e2308 href="http://dx.doi.org/10.1016/j.iac.2015.12.014">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726305043">F1000 Recommendation</a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732045048"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d26898e2322 class=n-a></a>Nurmatov U, Dhami S, Arasi S, <i> et al.</i>: Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic overview of systematic reviews. <i>Clin Transl Allergy.</i> 2017; <b>7</b>: 24. <a target=xrefwindow id=d26898e2333 href="http://www.ncbi.nlm.nih.gov/pubmed/28794855">PubMed Abstract </a> | <a target=xrefwindow id=d26898e2336 href="http://dx.doi.org/10.1186/s13601-017-0159-6">Publisher Full Text </a> | <a target=xrefwindow id=d26898e2340 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5547534">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732045048">F1000 Recommendation</a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d26898e2353 class=n-a></a>Durham SR, Yang WH, Pedersen MR, <i> et al.</i>: Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. <i>J Allergy Clin Immunol.</i> 2006; <b>117</b>(4): 802–9. <a target=xrefwindow id=d26898e2364 href="http://www.ncbi.nlm.nih.gov/pubmed/16630937">PubMed Abstract </a> | <a target=xrefwindow id=d26898e2367 href="http://dx.doi.org/10.1016/j.jaci.2005.12.1358">Publisher Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d26898e2376 class=n-a></a>Didier A, Malling HJ, Worm M, <i> et al.</i>: Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis. <i>J Allergy Clin Immunol.</i> 2007; <b>120</b>(6): 1338–45. <a target=xrefwindow id=d26898e2387 href="http://www.ncbi.nlm.nih.gov/pubmed/17935764">PubMed Abstract </a> | <a target=xrefwindow id=d26898e2390 href="http://dx.doi.org/10.1016/j.jaci.2007.07.046">Publisher Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d26898e2399 class=n-a></a>Nolte H, Hébert J, Berman G, <i> et al.</i>: Randomized controlled trial of ragweed allergy immunotherapy tablet efficacy and safety in North American adults. <i>Ann Allergy Asthma Immunol.</i> 2013; <b>110</b>(6): 450–456.e4. <a target=xrefwindow id=d26898e2410 href="http://www.ncbi.nlm.nih.gov/pubmed/23706715">PubMed Abstract </a> | <a target=xrefwindow id=d26898e2413 href="http://dx.doi.org/10.1016/j.anai.2013.03.013">Publisher Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718004293"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d26898e2422 class=n-a></a>Creticos PS, Maloney J, Bernstein DI, <i> et al.</i>: Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults. <i>J Allergy Clin Immunol.</i> 2013; <b>131</b>(5): 1342–9.e6. <a target=xrefwindow id=d26898e2433 href="http://www.ncbi.nlm.nih.gov/pubmed/23622121">PubMed Abstract </a> | <a target=xrefwindow id=d26898e2436 href="http://dx.doi.org/10.1016/j.jaci.2013.03.019">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718004293">F1000 Recommendation</a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725732326"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d26898e2449 class=n-a></a>Demoly P, Emminger W, Rehm D, <i> et al.</i>: Effective treatment of house dust mite-induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trial. <i>J Allergy Clin Immunol.</i> 2016; <b>137</b>(2): 444–451.e8. <a target=xrefwindow id=d26898e2460 href="http://www.ncbi.nlm.nih.gov/pubmed/26292778">PubMed Abstract </a> | <a target=xrefwindow id=d26898e2463 href="http://dx.doi.org/10.1016/j.jaci.2015.06.036">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725732326">F1000 Recommendation</a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d26898e2477 class=n-a></a>Nayak AS, Atiee GJ, Dige E, <i> et al.</i>: Safety of ragweed sublingual allergy immunotherapy tablets in adults with allergic rhinoconjunctivitis. <i>Allergy Asthma Proc.</i> 2012; <b>33</b>(5): 404–10. <a target=xrefwindow id=d26898e2488 href="http://www.ncbi.nlm.nih.gov/pubmed/23026182">PubMed Abstract </a> | <a target=xrefwindow id=d26898e2491 href="http://dx.doi.org/10.2500/aap.2012.33.3605">Publisher Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d26898e2500 class=n-a></a>Corzo JL, Carrillo T, Pedemonte C, <i> et al.</i>: Tolerability during double-blind randomized phase I trials with the house dust mite allergy immunotherapy tablet in adults and children. <i>J Investig Allergol Clin Immunol.</i> 2014; <b>24</b>(3): 154–61. <a target=xrefwindow id=d26898e2511 href="http://www.ncbi.nlm.nih.gov/pubmed/25011352">PubMed Abstract </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d26898e2520 class=n-a></a>Nolte H, Bernstein DI, Kleine-Tebbe JR, <i> et al.</i>: Efficacy and Safety of the SQ-House Dust Mite Sublingual Immunotherapy Tablet in North American Children and Adults: Findings from a Large Randomized, Placebo-Controlled Clinical Trial. <i>J Allergy Clin Immunol.</i> 2016; <b>137</b>(2 Suppl): AB409. <a target=xrefwindow id=d26898e2531 href="http://dx.doi.org/10.1016/j.jaci.2015.12.1266">Publisher Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718228277"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d26898e2540 class=n-a></a>Bergmann KC, Demoly P, Worm M, <i> et al.</i>: Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis. <i>J Allergy Clin Immunol.</i> 2014; <b>133</b>(6): 1608–14.e6. <a target=xrefwindow id=d26898e2551 href="http://www.ncbi.nlm.nih.gov/pubmed/24388010">PubMed Abstract </a> | <a target=xrefwindow id=d26898e2554 href="http://dx.doi.org/10.1016/j.jaci.2013.11.012">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718228277">F1000 Recommendation</a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726585402"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d26898e2567 class=n-a></a>Okamoto Y, Fujieda S, Okano M, <i> et al.</i>: House dust mite sublingual tablet is effective and safe in patients with allergic rhinitis. <i>Allergy.</i> 2017; <b>72</b>(3): 435–43. <a target=xrefwindow id=d26898e2578 href="http://www.ncbi.nlm.nih.gov/pubmed/27471838">PubMed Abstract </a> | <a target=xrefwindow id=d26898e2581 href="http://dx.doi.org/10.1111/all.12996">Publisher Full Text </a> | <a target=xrefwindow id=d26898e2585 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5324568">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726585402">F1000 Recommendation</a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d26898e2598 class=n-a></a>Nolte H, Casale TB, Lockey RF, <i> et al.</i>: Epinephrine Use in Clinical Trials of Sublingual Immunotherapy Tablets. <i>J Allergy Clin Immunol Pract.</i> 2017; <b>5</b>(1): 84–89.e3. <a target=xrefwindow id=d26898e2609 href="http://www.ncbi.nlm.nih.gov/pubmed/27838323">PubMed Abstract </a> | <a target=xrefwindow id=d26898e2612 href="http://dx.doi.org/10.1016/j.jaip.2016.08.017">Publisher Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d26898e2622 class=n-a></a>Nolte H, Amar N, Bernstein DI, <i> et al.</i>: Safety and tolerability of a short ragweed sublingual immunotherapy tablet. <i>Ann Allergy Asthma Immunol.</i> 2014; <b>113</b>(1): 93–100.e3. <a target=xrefwindow id=d26898e2633 href="http://www.ncbi.nlm.nih.gov/pubmed/24836393">PubMed Abstract </a> | <a target=xrefwindow id=d26898e2636 href="http://dx.doi.org/10.1016/j.anai.2014.04.018">Publisher Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d26898e2645 class=n-a></a>Durham SR, Emminger W, Kapp A, <i> et al.</i>: SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial. <i>J Allergy Clin Immunol.</i> 2012; <b>129</b>(3): 717–725.e5. <a target=xrefwindow id=d26898e2656 href="http://www.ncbi.nlm.nih.gov/pubmed/22285278">PubMed Abstract </a> | <a target=xrefwindow id=d26898e2659 href="http://dx.doi.org/10.1016/j.jaci.2011.12.973">Publisher Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d26898e2668 class=n-a></a>Didier A, Malling HJ, Worm M, <i> et al.</i>: Prolonged efficacy of the 300IR 5-grass pollen tablet up to 2 years after treatment cessation, as measured by a recommended daily combined score. <i>Clin Transl Allergy.</i> 2015; <b>5</b>: 12. <a target=xrefwindow id=d26898e2679 href="http://www.ncbi.nlm.nih.gov/pubmed/26097680">PubMed Abstract </a> | <a target=xrefwindow id=d26898e2682 href="http://dx.doi.org/10.1186/s13601-015-0057-8">Publisher Full Text </a> | <a target=xrefwindow id=d26898e2686 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4474569">Free Full Text </a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727303961"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d26898e2695 class=n-a></a>Scadding GW, Calderon MA, Shamji MH, <i> et al.</i>: Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis: The GRASS Randomized Clinical Trial. <i>JAMA.</i> 2017; <b>317</b>(6): 615–25. <a target=xrefwindow id=d26898e2706 href="http://www.ncbi.nlm.nih.gov/pubmed/28196255">PubMed Abstract </a> | <a target=xrefwindow id=d26898e2709 href="http://dx.doi.org/10.1001/jama.2016.21040">Publisher Full Text </a> | <a target=xrefwindow id=d26898e2713 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5479315">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727303961">F1000 Recommendation</a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727795776"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d26898e2726 class=n-a></a>Valovirta E, Petersen TH, Piotrowska T, <i> et al.</i>: Results from the 5-year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy. <i>J Allergy Clin Immunol.</i> 2018; <b>141</b>(2): 529–538.e13. <a target=xrefwindow id=d26898e2737 href="http://www.ncbi.nlm.nih.gov/pubmed/28689794">PubMed Abstract </a> | <a target=xrefwindow id=d26898e2740 href="http://dx.doi.org/10.1016/j.jaci.2017.06.014">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727795776">F1000 Recommendation</a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d26898e2753 class=n-a></a>Tucker MH, Tankersley MS, ACAAI Immunotherapy and Diagnostics Committee: Perception and practice of sublingual immunotherapy among practicing allergists. <i>Ann Allergy Asthma Immunol.</i> 2008; <b>101</b>(4): 419–25. <a target=xrefwindow id=d26898e2761 href="http://www.ncbi.nlm.nih.gov/pubmed/18939732">PubMed Abstract </a> | <a target=xrefwindow id=d26898e2764 href="http://dx.doi.org/10.1016/S1081-1206(10)60320-1">Publisher Full Text </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a name=d26898e2774 class=n-a></a>Sikora JM, Tankersley MS, ACAAI Immunotherapy and Diagnostics Committee: Perception and practice of sublingual immunotherapy among practicing allergists in the United States: a follow-up survey. <i>Ann Allergy Asthma Immunol.</i> 2013; <b>110</b>(3): 194–197.e4. <a target=xrefwindow id=d26898e2782 href="http://www.ncbi.nlm.nih.gov/pubmed/23548531">PubMed Abstract </a> | <a target=xrefwindow id=d26898e2785 href="http://dx.doi.org/10.1016/j.anai.2012.12.014">Publisher Full Text </a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733806208"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d26898e2794 class=n-a></a>Larenas-Linnemann DE, Mösges R: Dosing of European sublingual immunotherapy maintenance solutions relative to monthly recommended dosing of subcutaneous immunotherapy. <i>Allergy Asthma Proc.</i> 2016; <b>37</b>(1): 50–6. <a target=xrefwindow id=d26898e2802 href="http://www.ncbi.nlm.nih.gov/pubmed/26831847">PubMed Abstract </a> | <a target=xrefwindow id=d26898e2805 href="http://dx.doi.org/10.2500/aap.2016.37.3907">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733806208">F1000 Recommendation</a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d26898e2818 class=n-a></a>Moreno Benítez F, Espinazo Romeu M, Letrán Camacho A, <i> et al.</i>: Variation in allergen content in sublingual allergen immunotherapy with house dust mites. <i>Allergy.</i> 2015; <b>70</b>(11): 1413–20. <a target=xrefwindow id=d26898e2829 href="http://www.ncbi.nlm.nih.gov/pubmed/26185961">PubMed Abstract </a> | <a target=xrefwindow id=d26898e2832 href="http://dx.doi.org/10.1111/all.12694">Publisher Full Text </a> | <a target=xrefwindow id=d26898e2836 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5049613">Free Full Text </a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a name=d26898e2845 class=n-a></a>Amar SM, Harbeck RJ, Sills M, <i> et al.</i>: Response to sublingual immunotherapy with grass pollen extract: monotherapy versus combination in a multiallergen extract. <i>J Allergy Clin Immunol.</i> 2009; <b>124</b>(1): 150–156.e1-5. <a target=xrefwindow id=d26898e2856 href="http://www.ncbi.nlm.nih.gov/pubmed/19523672">PubMed Abstract </a> | <a target=xrefwindow id=d26898e2859 href="http://dx.doi.org/10.1016/j.jaci.2009.04.037">Publisher Full Text </a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d26898e2868 class=n-a></a>Klimek L, Uhlig J, Mösges R, <i> et al.</i>: A high polymerized grass pollen extract is efficacious and safe in a randomized double-blind, placebo-controlled study using a novel up-dosing cluster-protocol. <i>Allergy.</i> 2014; <b>69</b>(12): 1629–38. <a target=xrefwindow id=d26898e2879 href="http://www.ncbi.nlm.nih.gov/pubmed/25130503">PubMed Abstract </a> | <a target=xrefwindow id=d26898e2882 href="http://dx.doi.org/10.1111/all.12513">Publisher Full Text </a> | <a target=xrefwindow id=d26898e2886 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4238814">Free Full Text </a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726230537"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d26898e2895 class=n-a></a>Rondón C, Campo P, Salas M, <i> et al.</i>: Efficacy and safety of <i>D. pteronyssinus</i> immunotherapy in local allergic rhinitis: a double-blind placebo-controlled clinical trial. <i>Allergy.</i> 2016; <b>71</b>(7): 1057–61. <a target=xrefwindow id=d26898e2909 href="http://www.ncbi.nlm.nih.gov/pubmed/27008542">PubMed Abstract </a> | <a target=xrefwindow id=d26898e2913 href="http://dx.doi.org/10.1111/all.12889">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726230537">F1000 Recommendation</a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732150146"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d26898e2927 class=n-a></a>Rondón C, Blanca-López N, Campo P, <i> et al.</i>: Specific immunotherapy in local allergic rhinitis: A randomized, double-blind placebo-controlled trial with <i>Phleum pratense</i> subcutaneous allergen immunotherapy. <i>Allergy.</i> 2018; <b>73</b>(4): 905–15. <a target=xrefwindow id=d26898e2941 href="http://www.ncbi.nlm.nih.gov/pubmed/29168570">PubMed Abstract </a> | <a target=xrefwindow id=d26898e2945 href="http://dx.doi.org/10.1111/all.13350">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732150146">F1000 Recommendation</a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732385769"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d26898e2958 class=n-a></a>Bożek A, Kołodziejczyk K, Jarząb J: Efficacy and safety of birch pollen immunotherapy for local allergic rhinitis. <i>Ann Allergy Asthma Immunol.</i> 2018; <b>120</b>(1): 53–8. <a target=xrefwindow id=d26898e2966 href="http://www.ncbi.nlm.nih.gov/pubmed/29273130">PubMed Abstract </a> | <a target=xrefwindow id=d26898e2969 href="http://dx.doi.org/10.1016/j.anai.2017.10.009">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732385769">F1000 Recommendation</a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a name=d26898e2982 class=n-a></a>Durham SR, Creticos PS, Nelson HS, <i> et al.</i>: Treatment effect of sublingual immunotherapy tablets and pharmacotherapies for seasonal and perennial allergic rhinitis: Pooled analyses. <i>J Allergy Clin Immunol.</i> 2016; <b>138</b>(4): 1081–1088.e4. <a target=xrefwindow id=d26898e2993 href="http://www.ncbi.nlm.nih.gov/pubmed/27527264">PubMed Abstract </a> | <a target=xrefwindow id=d26898e2996 href="http://dx.doi.org/10.1016/j.jaci.2016.04.061">Publisher Full Text </a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718008509"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d26898e3005 class=n-a></a>Kiel MA, Röder E, van Gerth WR, <i> et al.</i>: Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy. <i>J Allergy Clin Immunol.</i> 2013; <b>132</b>(2): 353–60.e2. <a target=xrefwindow id=d26898e3016 href="http://www.ncbi.nlm.nih.gov/pubmed/23651609">PubMed Abstract </a> | <a target=xrefwindow id=d26898e3019 href="http://dx.doi.org/10.1016/j.jaci.2013.03.013">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718008509">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 23 Aug 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-1333/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-1333/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Department of Medicine, Division of Allergy/Immunology, National Jewish Health, Denver, CO, 80206, USA<br/> <p> <div class=margin-bottom> Flavia C. L. Hoyte <br/> <span>Roles: </span> Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Harold S. Nelson <br/> <span>Roles: </span> Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/7-1333/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 23 Aug 2018, 7:1333 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.15367.1">https://doi.org/10.12688/f1000research.15367.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2018 Hoyte FCL and Nelson HS. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=16746 data-id=15367 data-downloads="" data-views="" data-scholar="10.12688/f1000research.15367.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/7-1333/v1/pdf?article_uuid=6b3fe346-bb91-462d-9ad0-b3f2c743ca8c" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.15367.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Hoyte FCL and Nelson HS. Recent advances in allergic rhinitis [version 1; peer review: 2 approved] <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1333 (<a href="https://doi.org/10.12688/f1000research.15367.1" target=_blank>https://doi.org/10.12688/f1000research.15367.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=15367 id=mobile-track-article-signin-15367 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/15367?target=/articles/7-1333/v1"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=16746 /> <input name=articleId type=hidden value=15367 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Miguel Blanca</strong>, Allergy Unit, Regional University Hospital of Malaga, Spain </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Cemal Cingi</strong>, ENT Department, Medical Faculty, Eskisehir Osmangazi University, Turkey </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 23 Aug 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-1333/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-1333/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=37876-37177></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=37875-37176></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/7-1333/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>23 Aug 18</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Miguel Blanca</strong>, Allergy Unit, Regional University Hospital of Malaga, Spain </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Cemal Cingi</strong>, ENT Department, Medical Faculty, Eskisehir Osmangazi University, Turkey </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/7-1333/v1&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/7-1333/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent advances in allergic rhinitis".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/7-1333/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/7-1333/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/7-1333/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Hoyte FCL and Nelson HS');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/7-1333/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/7-1333",
            templates : {
                twitter : "Recent advances in allergic rhinitis. Hoyte FCL and Nelson HS, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/7-1333/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent advances in allergic rhinitis", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent advances in allergic rhinitis", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/15367/16746")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "16746");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "37176": 0,
                           "37177": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "fe5bba1c-4156-4bf1-a4a7-c0de6a59a801";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1333.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1333.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1333.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/7-1333.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/7-1333.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>